Skip to main content

Table 2 Allele frequency

From: CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer

SNP

n

Genotype frequency

HWE (p)

rs13181 ERCC2

78

19 GG (24.4 %)

35 GT (44.9 %)

24 TT (30.8 %)

0.53

rs3212986 ERCC1

78

10 AA (12.8 %)

24 AC (30.8 %)

44 CC (56.4 %)

0.72

rs 11615 ERCC1

78

27 AA (34.6 %)

36 AG (46.2 %)

15 GG (19.2 %)

0.58

rs 1799793 ERCC2

78

25 CC (32.1 %)

40 AG CT (51.3 %)

13 TT (16.7 %)

0.58

rs 7761731 CYP39A1

77

33 AA (42.9 %)

36 AT (46.8 %)

8 TT (10.4 %)

0.66

rs 25487 XRCC1

78

36 CC (46.2 %)

36 CT (46.2 %)

6 TT (7.7 %)

0.69

rs11045585 SLCO1B3

77

49 AA (63.8 %)

26 AG (33.3 %)

2 GG (2.6 %)

0.50